Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease

Tiffany M. Powell, Jonathan D. Paul, Jonathan M. Hill, Michael Thompson, Moshe Benjamin, Maria Rodrigo, J. Philip McCoy, Elizabeth J. Read, Hanh M. Khuu, Susan F. Leitman, Toren Finkel, Richard O. Cannon

Research output: Contribution to journalArticle

Abstract

Objective - Endothelial progenitor cells (EPCs) that may repair vascular injury are reduced in patients with coronary artery disease (CAD). We reasoned that EPC number and function may be increased by granulocyte colony-stimulating factor (G-CSF) used to mobilize hematopoietic progenitor cells in healthy donors. Methods and Results - Sixteen CAD patients had reduced CD34 +/CD133 + (0.0224±0.0063% versus 0.121±0.038% mononuclear cells [MNCs], P+/VEGFR-2 + cells, consistent with EPC phenotype (0.00033±0.00015% versus 0.0017±0.0006% MNCs, P+/CD133 + cells from 0.5±0.2/μL to 59.5±10.6/μL and CD133 +/ VEGFR-2 + cells from 0.007±0.004/μL to 1.9±0.6/μL (both P+ cells that coexpressed the homing receptor CXCR4 (30.4±8.3/μL, P

Original languageEnglish (US)
Pages (from-to)296-301
Number of pages6
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume25
Issue number2
DOIs
StatePublished - Feb 2005
Externally publishedYes

Fingerprint

Granulocyte Colony-Stimulating Factor
Coronary Artery Disease
Vascular Endothelial Growth Factor Receptor-2
CXCR4 Receptors
Vascular System Injuries
Hematopoietic Stem Cells
Endothelial Progenitor Cells
Cell Count
Tissue Donors
Phenotype

Keywords

  • Angiogenesis
  • Atherosclerosis
  • Cell adhesion molecules
  • Cells
  • Coronary disease

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease. / Powell, Tiffany M.; Paul, Jonathan D.; Hill, Jonathan M.; Thompson, Michael; Benjamin, Moshe; Rodrigo, Maria; McCoy, J. Philip; Read, Elizabeth J.; Khuu, Hanh M.; Leitman, Susan F.; Finkel, Toren; Cannon, Richard O.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 25, No. 2, 02.2005, p. 296-301.

Research output: Contribution to journalArticle

Powell, TM, Paul, JD, Hill, JM, Thompson, M, Benjamin, M, Rodrigo, M, McCoy, JP, Read, EJ, Khuu, HM, Leitman, SF, Finkel, T & Cannon, RO 2005, 'Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease', Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 2, pp. 296-301. https://doi.org/10.1161/01.ATV.0000151690.43777.e4
Powell, Tiffany M. ; Paul, Jonathan D. ; Hill, Jonathan M. ; Thompson, Michael ; Benjamin, Moshe ; Rodrigo, Maria ; McCoy, J. Philip ; Read, Elizabeth J. ; Khuu, Hanh M. ; Leitman, Susan F. ; Finkel, Toren ; Cannon, Richard O. / Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease. In: Arteriosclerosis, Thrombosis, and Vascular Biology. 2005 ; Vol. 25, No. 2. pp. 296-301.
@article{f5879271149a4f8481867d83a7288880,
title = "Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease",
abstract = "Objective - Endothelial progenitor cells (EPCs) that may repair vascular injury are reduced in patients with coronary artery disease (CAD). We reasoned that EPC number and function may be increased by granulocyte colony-stimulating factor (G-CSF) used to mobilize hematopoietic progenitor cells in healthy donors. Methods and Results - Sixteen CAD patients had reduced CD34 +/CD133 + (0.0224±0.0063{\%} versus 0.121±0.038{\%} mononuclear cells [MNCs], P+/VEGFR-2 + cells, consistent with EPC phenotype (0.00033±0.00015{\%} versus 0.0017±0.0006{\%} MNCs, P+/CD133 + cells from 0.5±0.2/μL to 59.5±10.6/μL and CD133 +/ VEGFR-2 + cells from 0.007±0.004/μL to 1.9±0.6/μL (both P+ cells that coexpressed the homing receptor CXCR4 (30.4±8.3/μL, P",
keywords = "Angiogenesis, Atherosclerosis, Cell adhesion molecules, Cells, Coronary disease",
author = "Powell, {Tiffany M.} and Paul, {Jonathan D.} and Hill, {Jonathan M.} and Michael Thompson and Moshe Benjamin and Maria Rodrigo and McCoy, {J. Philip} and Read, {Elizabeth J.} and Khuu, {Hanh M.} and Leitman, {Susan F.} and Toren Finkel and Cannon, {Richard O.}",
year = "2005",
month = "2",
doi = "10.1161/01.ATV.0000151690.43777.e4",
language = "English (US)",
volume = "25",
pages = "296--301",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease

AU - Powell, Tiffany M.

AU - Paul, Jonathan D.

AU - Hill, Jonathan M.

AU - Thompson, Michael

AU - Benjamin, Moshe

AU - Rodrigo, Maria

AU - McCoy, J. Philip

AU - Read, Elizabeth J.

AU - Khuu, Hanh M.

AU - Leitman, Susan F.

AU - Finkel, Toren

AU - Cannon, Richard O.

PY - 2005/2

Y1 - 2005/2

N2 - Objective - Endothelial progenitor cells (EPCs) that may repair vascular injury are reduced in patients with coronary artery disease (CAD). We reasoned that EPC number and function may be increased by granulocyte colony-stimulating factor (G-CSF) used to mobilize hematopoietic progenitor cells in healthy donors. Methods and Results - Sixteen CAD patients had reduced CD34 +/CD133 + (0.0224±0.0063% versus 0.121±0.038% mononuclear cells [MNCs], P+/VEGFR-2 + cells, consistent with EPC phenotype (0.00033±0.00015% versus 0.0017±0.0006% MNCs, P+/CD133 + cells from 0.5±0.2/μL to 59.5±10.6/μL and CD133 +/ VEGFR-2 + cells from 0.007±0.004/μL to 1.9±0.6/μL (both P+ cells that coexpressed the homing receptor CXCR4 (30.4±8.3/μL, P

AB - Objective - Endothelial progenitor cells (EPCs) that may repair vascular injury are reduced in patients with coronary artery disease (CAD). We reasoned that EPC number and function may be increased by granulocyte colony-stimulating factor (G-CSF) used to mobilize hematopoietic progenitor cells in healthy donors. Methods and Results - Sixteen CAD patients had reduced CD34 +/CD133 + (0.0224±0.0063% versus 0.121±0.038% mononuclear cells [MNCs], P+/VEGFR-2 + cells, consistent with EPC phenotype (0.00033±0.00015% versus 0.0017±0.0006% MNCs, P+/CD133 + cells from 0.5±0.2/μL to 59.5±10.6/μL and CD133 +/ VEGFR-2 + cells from 0.007±0.004/μL to 1.9±0.6/μL (both P+ cells that coexpressed the homing receptor CXCR4 (30.4±8.3/μL, P

KW - Angiogenesis

KW - Atherosclerosis

KW - Cell adhesion molecules

KW - Cells

KW - Coronary disease

UR - http://www.scopus.com/inward/record.url?scp=19944433719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19944433719&partnerID=8YFLogxK

U2 - 10.1161/01.ATV.0000151690.43777.e4

DO - 10.1161/01.ATV.0000151690.43777.e4

M3 - Article

C2 - 15569821

AN - SCOPUS:19944433719

VL - 25

SP - 296

EP - 301

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 2

ER -